# SweetDeep: A Wearable AI Solution for Real-Time Non-Invasive Diabetes Screening

arXiv: https://arxiv.org/abs/2512.03471 · HTML: https://mlsanity.com/paper/2512.03471/

## Key facts

- No citing papers in the map yet (data through 14 Oct 2026).
- Builds on 9 of its 43 references that are in the map.
- First posted on arXiv 3 Dec 2025.

## Builds on (most cited first, 9 of 9)

- [Attention Is All You Need](https://mlsanity.com/paper/1706.03762/) (2017)
- [Adam: A Method for Stochastic Optimization](https://mlsanity.com/paper/1412.6980/) (2014)
- [Batch Normalization: Accelerating Deep Network Training by Reducing Internal Covariate Shift](https://mlsanity.com/paper/1502.03167/) (2015)
- [On Calibration of Modern Neural Networks](https://mlsanity.com/paper/1706.04599/) (2017)
- [Can You Trust Your Model's Uncertainty? Evaluating Predictive Uncertainty Under Dataset Shift](https://mlsanity.com/paper/1906.02530/) (2019)
- [Macro F1 and Macro F1](https://mlsanity.com/paper/1911.03347/) (2019)
- [DiabDeep: Pervasive Diabetes Diagnosis based on Wearable Medical Sensors and Efficient Neural Networks](https://mlsanity.com/paper/1910.04925/) (2019)
- [Location-aware Adaptive Normalization: A Deep Learning Approach For Wildfire Danger Forecasting](https://mlsanity.com/paper/2212.08208/) (2022)
- [Temporal Encoding Strategies for Energy Time Series Prediction](https://mlsanity.com/paper/2503.15456/) (2025)

## Abstract (arXiv)

The global rise in type 2 diabetes underscores the need for scalable and cost-effective screening methods. Current diagnosis requires biochemical assays, which are invasive and costly. Advances in consumer wearables have enabled early explorations of machine learning-based disease detection, but prior studies were limited to controlled settings. We present SweetDeep, a compact neural network trained on physiological and demographic data from 285 (diabetic and non-diabetic) participants in the EU and MENA regions, collected using Samsung Galaxy Watch 7 devices in free-living conditions over six days. Each participant contributed multiple 2-minute sensor recordings per day, totaling approximately 20 recordings per individual. Despite comprising fewer than 3,000 parameters, SweetDeep achieves 82.5% patient-level accuracy (82.1% macro-F1, 79.7% sensitivity, 84.6% specificity) under three-fold cross-validation, with an expected calibration error of 5.5%. Allowing the model to abstain on less than 10% of low-confidence patient predictions yields an accuracy of 84.5% on the remaining patients. These findings demonstrate that combining engineered features with lightweight architectures can support accurate, rapid, and generalizable detection of type 2 diabetes in real-world wearable settings.